Catalyst Wire Dossier Catalyst Wire Dossier

Neurolief Ltd. RIME Study device

· Neurolief Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Neurolief Ltd. RIME Study device, covering 2022-07-12 to 2022-07-12. Get the full timeline:

Most recent: Clinical Trial Update: The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine [NA]

See pricing